Elevated Transferrin Saturation and Risk of Diabetes: Three population-based studies

Por Ellervik, Christina, Mandrup-Poulsen, Thomas, Andersen, Henrik Ullits, Tybjærg-Hansen, Anne, Frandsen, Merete, Birgens, Henrik, Nordestgaard, Børge G.
Publicado em 2011

Total Mortality by Elevated Transferrin Saturation in Patients With Diabetes

Por Ellervik, Christina, Andersen, Henrik Ullits, Tybjærg-Hansen, Anne, Frandsen, Merete, Birgens, Henrik, Nordestgaard, Børge G., Mandrup-Poulsen, Thomas
Publicado em 2013

Changes in HbA1c and Weight Following Transition to Continuous Subcutaneous Insulin Infusion Therapy in Adults With Type 1 Diabetes

Por Mehta, Sanjeev N., Andersen, Henrik Ullits, Abrahamson, Martin J., Wolpert, Howard A., Hommel, Eva E., McMullen, William, Ridderstråle, Martin
Publicado no J Diabetes Sci Technol (2016)

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomis...

Por Dejgaard, Thomas Fremming, Knop, Filip Krag, Tarnow, Lise, Frandsen, Christian Seerup, Hansen, Tanja Stenbæk, Almdal, Thomas, Holst, Jens Juul, Madsbad, Sten, Andersen, Henrik Ullits
Publicado no BMJ Open (2015)

Identification of possible adverse drug reactions in clinical notes: The case of glucose-lowering medicines

Por Warrer, Pernille, Jensen, Peter Bjødstrup, Aagaard, Lise, Jensen, Lars Juhl, Brunak, Søren, Krag, Malene Hammer, Rossing, Peter, Almdal, Thomas, Andersen, Henrik Ullits, Hansen, Ebba Holme
Publicado no J Res Pharm Pract (2015)